Cargando…
After Treatment Decrease of Bone Marrow Tregs and Outcome in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia
An emerging body of evidence demonstrates that defects in antileukemic effector cells in patients with acute myeloid leukemia (AML) can contribute to the development and/or persistence of the disease. In particular, immune suppressive regulatory T cells (Tregs) may contribute to this defective antil...
Autores principales: | Delia, Mario, Carluccio, Paola, Mestice, Anna, Frappampina, Roberta, Albano, Francesco, Specchia, Giorgina, Musto, Pellegrino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657695/ https://www.ncbi.nlm.nih.gov/pubmed/33204734 http://dx.doi.org/10.1155/2020/2134647 |
Ejemplares similares
-
Impact of Bone Marrow Aspirate Tregs on the Response Rate of Younger Newly Diagnosed Acute Myeloid Leukemia Patients
por: Delia, Mario, et al.
Publicado: (2018) -
Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment
por: Piccolomo, Antonio, et al.
Publicado: (2020) -
Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?
por: Tarantini, Francesco, et al.
Publicado: (2021) -
Single-Cell Sequencing: Ariadne’s Thread in the Maze of Acute Myeloid Leukemia
por: Redavid, Immacolata, et al.
Publicado: (2022) -
A Crumbled but Fatal Acute Leukemia
por: Tarantini, Francesco, et al.
Publicado: (2022)